Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?

被引:12
作者
Morange, Pierre-Emmanuel [1 ]
Tregouet, David-Alexandre [2 ]
机构
[1] Univ Mediterranean, Fac Med, INSERM, UMR S626, Marseille, France
[2] Univ Paris 06, INSERM, UMR S937, Paris, France
关键词
genetics of thrombosis and haemostasis; epidemiology; venous thrombosis; GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; FACTOR-V-LEIDEN; ACTIVATABLE FIBRINOLYSIS INHIBITOR; QUANTITATIVE-TRAIT LOCUS; FACTOR PATHWAY INHIBITOR; COMMON GENETIC-VARIATION; COPY NUMBER VARIATION; FACTOR-XII GENE; RISK-FACTOR;
D O I
10.1111/j.1365-2141.2009.07975.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Venous thromboembolism (VTE) is a frequent disease that has a major genetic component of risk. However, known identified genetic risk factors account for <30% of idiopathic (without any environmental origin) VTE cases. This article aims to review the lessons learnt during recent decades in the field of the genetics of VTE, describe the present state-of-art methods and discuss promising themes for finding new susceptibility loci.
引用
收藏
页码:495 / 506
页数:12
相关论文
共 50 条
  • [31] Fatty liver and nonalcoholic steatohepatitis - Where do we stand and where are we going?
    Lonardo, A
    DIGESTIVE DISEASES, 1999, 17 (02) : 80 - 89
  • [32] Results of the Spanish National Polytrauma Registry. Where are we and where are we heading?
    Campos-Serra, Andrea
    Perez-Diaz, Lola
    Rey-Valcarcel, Cristina
    Montmany-Vioque, Sandra
    Artiles-Armas, Manuel
    Aparicio-Sanchez, Daniel
    Tallon-Aguilar, Luis
    Gutierrez-Andreu, Marta
    Bernal-Tirapo, Julia
    Nisa, Francisca Garcia-Moreno
    Vera-Mansilla, Cristina
    Gonzalez-Conde, Ricardo
    Gomez-Viana, Leticia
    Titos-Garcia, Alberto
    Aranda-Narvaez, Jose
    CIRUGIA ESPANOLA, 2023, 101 (09): : 609 - 616
  • [33] Genetics in Keratoconus: where are we?
    Bykhovskaya, Yelena
    Margines, Benjamin
    Rabinowitz, Yaron S.
    EYE AND VISION, 2016, 3
  • [34] Leprosy and HIV, where are we at?
    Lockwood, Diana N. J.
    Lambert, Saba M.
    LEPROSY REVIEW, 2010, 81 (03) : 169 - 175
  • [35] Melanoma etiology: where are we?
    Tucker, MA
    Goldstein, AM
    ONCOGENE, 2003, 22 (20) : 3042 - 3052
  • [36] Vision 2020: where are we?
    Bourne, Rupert R. A.
    CURRENT OPINION IN OPHTHALMOLOGY, 2020, 31 (02) : 81 - 84
  • [37] Uric Acid: Where Are We?
    Rosendorff, Clive
    Jogendra, Mather R. D.
    JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (01) : 5 - 6
  • [38] Melanoma etiology: where are we?
    Margaret A Tucker
    Alisa M Goldstein
    Oncogene, 2003, 22 : 3042 - 3052
  • [39] Mathematical modelling of the propagation of infectious diseases: Where we came from, and where we are going
    Jose Fresnadillo-Martinez, Maria
    Garcia-Sanchez, Enrique
    Garcia-Merino, Enrique
    Martin del Rey, Angel
    Elias Garcia-Sanchez, Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2013, 26 (02) : 81 - 91
  • [40] The Genetic Epidemiological Landscape of Hip and Knee Osteoarthritis: Where Are We Now and Where Are We Going?
    Zengini, Eleni
    Finan, Chris
    Wilkinson, J. Mark
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 260 - 266